Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01394055 · ClinicalTrials.gov registry record · Phase 1
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
A Phase 1 study of Gastroparesis and Gastrointestinal Motility Disorder, sponsored by Motus Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01394055 is a Phase 1 study of Gastroparesis and Gastrointestinal Motility Disorder that has completed, run by Motus Therapeutics. The registered enrollment target is 20 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01394055, a Phase 1 study of Gastroparesis and Gastrointestinal Motility Disorder, has completed, sponsored by Motus Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the pharmacodynamic (PD) and pharmacokinetic (PK) profile and the safety and tolerability of RM-131 in patients with diabetes mellitus and delayed gastric emptying.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG RM-131
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01394055
The ClinicalTrials.gov registry entry for NCT01394055 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (93% lower). The listed sponsor is Motus Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Gastroparesis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01394055 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01394055 about?
NCT01394055 is a clinical study titled "Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis". The purpose of this study is to evaluate the pharmacodynamic (PD) and pharmacokinetic (PK) profile and the safety and tolerability of RM-131 in patients with diabetes mellitus and delayed gastric emptying.
What is the current status of trial NCT01394055?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2011-07. Estimated completion is 2012-12.
What conditions does trial NCT01394055 study?
This clinical trial studies the following conditions: Gastroparesis, Gastrointestinal Motility Disorder, Diabetes Mellitus Type 1 and 2, Diabetes Mellitus Complications.
What interventions are being tested in trial NCT01394055?
The interventions under investigation include: Placebo (DRUG), RM-131 (DRUG).
Who is sponsoring clinical trial NCT01394055?
This trial is sponsored by Motus Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01394055 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TENS in Scleroderma
RECRUITING · Phase 1
-
Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
COMPLETED · Phase 1
-
Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers
COMPLETED · Phase 1
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Study of Gastric Motility in Eosinophilic Gastritis
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.